Proteomics in Drug Discovery investors worldwide.

Proteomics in Drug Discovery investors

Fliar publishes 1 investor page for Proteomics in Drug Discovery. That is 1 investor list. The list with the most capital behind it is Proteomics in Drug Discovery investors in San Francisco ($5.2B across the rounds it covers).

By location, the biggest groups are San Francisco (1) and United States (1).

Close neighbours of Proteomics in Drug Discovery are AI Drug Discovery, Generative AI Drug Discovery, Cheminformatics for Drug Discovery, Genomics for Drug Discovery, Proteomics and IoT In Automotive.